Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMDP) Equity Ratio (2016 - 2025)

Historic Equity Ratio for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to 0.05.

  • LifeMD's Equity Ratio rose 17266.24% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year increase of 17266.24%. This contributed to the annual value of 0.12 for FY2024, which is 26663.77% down from last year.
  • Per LifeMD's latest filing, its Equity Ratio stood at 0.05 for Q3 2025, which was up 17266.24% from 0.02 recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Equity Ratio peaked at 0.47 during Q1 2022, and registered a low of 1.14 during Q3 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.04 (2021), whereas its average is 0.12.
  • Per our database at Business Quant, LifeMD's Equity Ratio skyrocketed by 115297.4% in 2022 and then tumbled by 79259.06% in 2023.
  • Quarter analysis of 5 years shows LifeMD's Equity Ratio stood at 0.46 in 2021, then tumbled by 201.54% to 0.46 in 2022, then surged by 115.49% to 0.07 in 2023, then plummeted by 266.64% to 0.12 in 2024, then surged by 142.76% to 0.05 in 2025.
  • Its Equity Ratio stands at 0.05 for Q3 2025, versus 0.02 for Q2 2025 and 0.03 for Q1 2025.